FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2091260715> ?p ?o ?g. }

• W2091260715 endingPage "e23" @default.
• W2091260715 startingPage "e23" @default.
• W2091260715 abstract "Development of resistance to imatinib mesylate (IM) in chronic myeloid leukemia (CML) patients is mediated by different mechanisms that can be classified as BCR-ABL dependent or BCR-ABL independent pathways. BCR-ABL dependent mechanisms are most frequently associated with point mutations in tyrosine kinase domain (TKD) of BCR-ABL1 and also with BCR-ABL gene amplification. Many different types and frequencies of mutations have been reported in different studies, probably due to the different composition of study cohorts. Since no reports are available from Malaysia, this study was undertaken to investigate the frequency and pattern of BCR-ABL kinase domain mutations using dHPLC followed by sequencing, and also status of BCR-ABL gene amplification using fluorescence in situ hybridization (FISH) on 40 IM resistant Malaysian CML patients. Mutations were detected in 13 patients (32.5%). Five different types of mutations (T315I, E255K, Y253H, M351T, V289F) were identified in these patients. In the remaining 27 IM resistant CML patients, we investigated the contribution made by BCR-ABL gene amplification, but none of these patients showed amplification. It is presumed that the mechanisms of resistance in these 27 patients might be due to BCR-ABL independent pathways. Different mutations confer different levels of resistance and, therefore, detection and characterization of TKD mutations is highly important in order to guide therapy in CML patients." @default.
• W2091260715 created "2016-06-24" @default.
• W2091260715 creator A5051356701 @default.
• W2091260715 creator A5057608389 @default.
• W2091260715 creator A5059441493 @default.
• W2091260715 creator A5071472752 @default.
• W2091260715 creator A5074149248 @default.
• W2091260715 creator A5080878492 @default.
• W2091260715 creator A5085145907 @default.
• W2091260715 creator A5086550615 @default.
• W2091260715 date "2012-11-23" @default.
• W2091260715 modified "2023-10-16" @default.
• W2091260715 title "Contribution of BCR-ABL kinase domain mutations to imatinib mesylate resistance in Philadelphia chromosome positive Malaysian chronic myeloid leukemia patients" @default.
• W2091260715 cites W1500868774 @default.
• W2091260715 cites W1970229217 @default.
• W2091260715 cites W1986058924 @default.
• W2091260715 cites W1992121712 @default.
• W2091260715 cites W1995670055 @default.
• W2091260715 cites W2013477475 @default.
• W2091260715 cites W2015616444 @default.
• W2091260715 cites W2016691725 @default.
• W2091260715 cites W2040033475 @default.
• W2091260715 cites W2065514651 @default.
• W2091260715 cites W2103013933 @default.
• W2091260715 cites W2107268345 @default.
• W2091260715 cites W2112897206 @default.
• W2091260715 cites W2120437980 @default.
• W2091260715 cites W2131022882 @default.
• W2091260715 cites W2148194527 @default.
• W2091260715 cites W2148389318 @default.
• W2091260715 cites W2150703483 @default.
• W2091260715 cites W2153432584 @default.
• W2091260715 cites W2166654361 @default.
• W2091260715 cites W4249096810 @default.
• W2091260715 doi "https://doi.org/10.4081/hr.2012.e23" @default.
• W2091260715 hasPubMedCentralId "https://www.ncbi.nlm.nih.gov/pmc/articles/3555211" @default.
• W2091260715 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/23355941" @default.
• W2091260715 hasPublicationYear "2012" @default.
• W2091260715 type Work @default.
• W2091260715 sameAs 2091260715 @default.
• W2091260715 citedByCount "10" @default.
• W2091260715 countsByYear W20912607152014 @default.
• W2091260715 countsByYear W20912607152015 @default.
• W2091260715 countsByYear W20912607152017 @default.
• W2091260715 countsByYear W20912607152018 @default.
• W2091260715 countsByYear W20912607152021 @default.
• W2091260715 crossrefType "journal-article" @default.
• W2091260715 hasAuthorship W2091260715A5051356701 @default.
• W2091260715 hasAuthorship W2091260715A5057608389 @default.
• W2091260715 hasAuthorship W2091260715A5059441493 @default.
• W2091260715 hasAuthorship W2091260715A5071472752 @default.
• W2091260715 hasAuthorship W2091260715A5074149248 @default.
• W2091260715 hasAuthorship W2091260715A5080878492 @default.
• W2091260715 hasAuthorship W2091260715A5085145907 @default.
• W2091260715 hasAuthorship W2091260715A5086550615 @default.
• W2091260715 hasBestOaLocation W20912607151 @default.
• W2091260715 hasConcept C104317684 @default.
• W2091260715 hasConcept C125418893 @default.
• W2091260715 hasConcept C126322002 @default.
• W2091260715 hasConcept C138626823 @default.
• W2091260715 hasConcept C143065580 @default.
• W2091260715 hasConcept C170493617 @default.
• W2091260715 hasConcept C2777583451 @default.
• W2091260715 hasConcept C2778729363 @default.
• W2091260715 hasConcept C2778904597 @default.
• W2091260715 hasConcept C3019892230 @default.
• W2091260715 hasConcept C32619005 @default.
• W2091260715 hasConcept C42362537 @default.
• W2091260715 hasConcept C43907098 @default.
• W2091260715 hasConcept C502942594 @default.
• W2091260715 hasConcept C54355233 @default.
• W2091260715 hasConcept C71924100 @default.
• W2091260715 hasConcept C86803240 @default.
• W2091260715 hasConceptScore W2091260715C104317684 @default.
• W2091260715 hasConceptScore W2091260715C125418893 @default.
• W2091260715 hasConceptScore W2091260715C126322002 @default.
• W2091260715 hasConceptScore W2091260715C138626823 @default.
• W2091260715 hasConceptScore W2091260715C143065580 @default.
• W2091260715 hasConceptScore W2091260715C170493617 @default.
• W2091260715 hasConceptScore W2091260715C2777583451 @default.
• W2091260715 hasConceptScore W2091260715C2778729363 @default.
• W2091260715 hasConceptScore W2091260715C2778904597 @default.
• W2091260715 hasConceptScore W2091260715C3019892230 @default.
• W2091260715 hasConceptScore W2091260715C32619005 @default.
• W2091260715 hasConceptScore W2091260715C42362537 @default.
• W2091260715 hasConceptScore W2091260715C43907098 @default.
• W2091260715 hasConceptScore W2091260715C502942594 @default.
• W2091260715 hasConceptScore W2091260715C54355233 @default.
• W2091260715 hasConceptScore W2091260715C71924100 @default.
• W2091260715 hasConceptScore W2091260715C86803240 @default.
• W2091260715 hasIssue "4" @default.
• W2091260715 hasLocation W20912607151 @default.
• W2091260715 hasLocation W20912607152 @default.
• W2091260715 hasLocation W20912607153 @default.
• W2091260715 hasLocation W20912607154 @default.
• W2091260715 hasLocation W20912607155 @default.
• W2091260715 hasOpenAccess W2091260715 @default.
• W2091260715 hasPrimaryLocation W20912607151 @default.

• next